Tags

Type your tag names separated by a space and hit enter

Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?
J Trauma Acute Care Surg. 2020 06; 88(6):713-714.JT

Authors+Show Affiliations

From the Department of Surgery (H.B.M., E.E.M., R.C.M.), University of Colorado Denver, Denver, Colorado; Koch Institute for Integrative Cancer Research, Center for Precision Cancer Medicine, Departments of Biological Engineering and Biology (C.D.B., M.B.Y.), Massachusetts Institute of Technology, Cambridge; Division of Acute Care Surgery, Trauma and Surgical Critical Care, Department of Surgery (C.D.B., M.B.Y.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; Department of Surgery (E.E.M.), Ernest E Moore Shock Trauma Center at Denver Health; Department of Medicine (P.K.M.), University of Colorado Denver, Denver, Colorado; Department of Anesthesia, Critical Care and Pain Medicine (D.S.T.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; and Department of Surgery (F.A.M.), University of Florida, Gainesville, Florida.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, P.H.S.

Language

eng

PubMed ID

32281766

Citation

Moore, Hunter B., et al. "Is There a Role for Tissue Plasminogen Activator as a Novel Treatment for Refractory COVID-19 Associated Acute Respiratory Distress Syndrome?" The Journal of Trauma and Acute Care Surgery, vol. 88, no. 6, 2020, pp. 713-714.
Moore HB, Barrett CD, Moore EE, et al. Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome? J Trauma Acute Care Surg. 2020;88(6):713-714.
Moore, H. B., Barrett, C. D., Moore, E. E., McIntyre, R. C., Moore, P. K., Talmor, D. S., Moore, F. A., & Yaffe, M. B. (2020). Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome? The Journal of Trauma and Acute Care Surgery, 88(6), 713-714. https://doi.org/10.1097/TA.0000000000002694
Moore HB, et al. Is There a Role for Tissue Plasminogen Activator as a Novel Treatment for Refractory COVID-19 Associated Acute Respiratory Distress Syndrome. J Trauma Acute Care Surg. 2020;88(6):713-714. PubMed PMID: 32281766.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome? AU - Moore,Hunter B, AU - Barrett,Christopher D, AU - Moore,Ernest E, AU - McIntyre,Robert C, AU - Moore,Peter K, AU - Talmor,Daniel S, AU - Moore,Frederick A, AU - Yaffe,Michael B, PY - 2020/4/14/pubmed PY - 2020/6/5/medline PY - 2020/4/14/entrez SP - 713 EP - 714 JF - The journal of trauma and acute care surgery JO - J Trauma Acute Care Surg VL - 88 IS - 6 SN - 2163-0763 UR - https://www.unboundmedicine.com/medline/citation/32281766/full_citation L2 - https://doi.org/10.1097/TA.0000000000002694 DB - PRIME DP - Unbound Medicine ER -